First and only Web-based solution for managing compliance and regulated content throughout the product lifecycle reduces costs, risk, and time-to-market
SAN DIEGO, June 22 /PRNewswire/ -- Drug Information Association 45th Annual Meeting -- Virtify, Inc., the market leader in enterprise content compliance solutions for life sciences companies, today announced the upcoming release of its Virtx integrated software suite, an end-to-end, Web-based solution for managing the complex content and compliance requirements in the highly regulated pharmaceutical, biotechnology, medical device, animal health and food sciences industries. Unlike traditional content management solutions or individual point products, the Virtx software suite provides a secure, collaborative online environment for managing regulated content throughout the entire life sciences product continuum. The Virtx suite is also pre-configured to comply with different global standards and regulatory mandates such as Clinical Trial Disclosure, Electronic Common Technical Document (eCTD), Structured Product Labeling (SPL) and other electronic submissions standards. At the same time, the Virtx software suite can accommodate future mandates and initiatives by global regulatory bodies.
"The cost of bringing new drugs to market ranges from $800 million to $1.2 billion and it's estimated that roughly 26% comes from the content requirements associated with regulatory compliance," said Alan Louie, Ph.D., research director for IDC Health Industry Insights. "Faced with the daunting challenge of upgrading fragmented, paper-based-processes that make timely postings and filings nearly impossible, life science companies are relying increasingly on new technologies to comply with the changing regulatory environment. The impact of non-compliance is significant, and includes costly product delays, regulatory fines
|SOURCE Virtify, Inc.|
Copyright©2009 PR Newswire.
All rights reserved